Areas of Focus

The OniX Empire Fund was established out of the collective ambition of investors experienced in the healthcare and business industries. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies.

We either develop our own companies or our partners receive personal guidance from the very first stages, and are provided with all the resources and expert advice they need. If you’d like to learn more about us or are interested in partnering with us, please submit a short non-confidential summary of your technology through out partner the OniX Hub at www.onixhub.com

​

Our areas of focus are:

1- Prevention and Early Diagnosis

​

2- Medical Food

Medical foods are distinguished from the broader category of foods for special dietary use by the requirement that medical foods be intended to meet distinctive nutritional requirements of a disease or condition, used under medical supervision, and intended for the specific dietary management of a disease or condition

​

3- Therapeutics

We build companies that discover, develop and commercialize innovative therapeutics that solve meaningful clinical problems. We seek real therapies. Our team takes a long-term perspective and works to create drugs that make a profound difference for patients and the standard of clinical care. Translational science lies at the core as we seek to partner with the best academic and industrial innovators to take their ideas beyond the lab. Great ideas attract great entrepreneurial teams and we invest in building companies around early innovations with the knowledge of what it takes to create a drug. We approach company building with a deep commitment to well-characterized biology, mechanistic understanding and mature, developable therapeutic modalities.

 i. Rare Neurological Diseases

ii. Rare Skin Disorders

iii. Women'n Health

v. Repurposing

​

4- Others

We are open to breakthrough ideas in several areas, including Triple Negative Breast Cancer, IBD, Medical Devices, Autoimmunity, Vaccines, Antimicrobial, Topicals, Agriculture, Energy, AI, and others

​